IKZF1 and acute lymphoblastic leukemia: IKZF1 deletions have been associated with a higher risk of relapse in ALL and have been shown to be a hallmark of BCR-ABL1-positive ALL, although they have also been identified in a fraction of BCR-ABL1-negative ALL patients [10,38,39,40,41,42,43], as noted in our study.